On September 10, 2020, Mediforum Pharmaceutical Incorporation (KOSDAQ:A047920) closed the transaction. The company issued 4,154,511 shares for gross proceeds of KRW 18,632,981,835 in its second and final tranche. The company received KRW 48,632,978,215 in the transaction.